3D EPID-based in vivo dosimetry for IMRT and VMAT

30Citations
Citations of this article
73Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this paper the various approaches of EPID-based in vivo IMRT and VMAT dose verification, and their clinical implementation, are described. It will be shown that EPID-based in vivo dosimetry plays an important role in the total chain of verification procedures in a radiotherapy department. EPID-based dosimetry, in combination with in-room imaging, is a fast and accurate tool for 3D in vivo verification of VMAT delivery. EPID-based in vivo dosimetry provides clinically more useful information and is less time consuming than patient-specific pre-treatment dose verification. In addition to accurate 3D dose verification, in vivo EPID-based dosimetry will also detect major errors in the dose received by individual patients, and provides a safety net for advanced treatments such as IMRT and VMAT.

Cite

CITATION STYLE

APA

Mijnheer, B., Olaciregui-Ruiz, I., Rozendaal, R., Sonke, J. J., Spreeuw, H., Tielenburg, R., … Mans, A. (2013). 3D EPID-based in vivo dosimetry for IMRT and VMAT. In Journal of Physics: Conference Series (Vol. 444). Institute of Physics Publishing. https://doi.org/10.1088/1742-6596/444/1/012011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free